Department for HIV, Tuberculosis, Hepatitis and STIs

Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections

The WHO Department leads the global effort to end the epidemics of HIV, tuberculosis (TB), hepatitis, and sexually transmitted infections (STIs), ensuring that every person has equitable access to highest-quality people-centred scientific evidence and services, regardless of who they are or where they live.

About us

Global Programmes

Global HIV Programme

Data & statistics on HIV

Global TB Programme

Data & statistics on TB

Global Hepatitis Programme

Data & statistics on hepatitis

Global STIs Programme

Data & statistics on STIs

Strategies & accountability

Global Health Sector Strategies on HIV, Hepatitis and STIs

The Strategies promote disease-specific goals to end AIDS and the epidemics of viral hepatitis and sexually transmitted infections by 2030, with 5 strategic directions providing the overall guiding framework for achieving these goals.

Implementing the global health sector strategies on HIV, hepatitis and STIs, 2022–2030: Report on progress and gaps 2024, second edition

End TB Strategy

Ending TB is not just a public health problem, but a development challenge and opportunity. WHO’s post-2015 End TB Strategy, adopted by the World Health Assembly in 2014, aims to end the global TB epidemic as part of the newly adopted Sustainable Development Goals.

Accountability Dashboard

At-a-glance accountability dashboard for progress on global strategies for HIV, Hepatitis and STIs with status on impact indicators, services delivered, and adoption of WHO policies. Country scorecards measure progress towards HIV incidence and mortality, and reaching service targets.

News

All →

18 December 2025

News release

WHO validates Brazil for eliminating mother-to-child transmission of HIV

16 December 2025

Departmental update

WHO’s new guidance on maintaining opioid agonist maintenance treatment as an essential health service

1 December 2025

News release

New prevention tools and investment in services essential in the fight against AIDS

26 November 2025

Departmental update

WHO releases policy brief on priority setting in TB programme planning

24 November 2025

Departmental update

WHO launches new framework to tackle drug resistance to HIV, hepatitis B and C, and STIs

1 (current)
2
3
4
5
6
7
8
9
10

Events

All →

Global webinar: WHO guidance on maintaining opioid agonist maintenance treatment as an essential health service

17 December 2025 11:00 – 12:15 CET

Global #ENDTB Youth Townhall: Mobilizing youth power to accelerate the TB response

12 December 2025 12:30 – 15:00 CET

#EndTB Webinar: Driving cross-sector collaboration to deliver people-centered TB care for migrants and refugees

9 December 2025 12:00 – 14:30 CET

World AIDS Day 2025: Geneva commemoration event

1 December 2025 15:30 – 18:00 CET

2025

World AIDS Day 2025 – Overcoming disruption, transforming the AIDS response

1 December 2025

1 (current)
2
3
4
5
6
7
8
9
10

Publications

All →

WHO updated recommendations on HIV clinical management: recommendations for a public health approach

This document provides an overview of the updated World Health Organization recommendations for HIV clinical management, which focus on optimizing antiretroviral...

Download

WHO guidelines on the management of advanced HIV disease

Advanced HIV disease is the major cause of AIDS-related deaths among people living with HIV. In 2017, WHO recommended a package of care that should ...

Download

WHO consultation on the use of broadly neutralizing antibodies for postnatal prophylaxis against the vertical transmission of HIV: meeting report, 22–23 May and 25 November 2024

Building on growing momentum from multiple stakeholders, this report summarizes the proceedings from a consultation held to convene a multidisciplinary...

Download

The Integrated Drug Resistance Action Framework for HIV, Hepatitis B and C, and Sexually Transmitted Infections (2026–2030) outlines a unified...

Download

Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP): gonorrhoea treatment optimization, 2024 report

The WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) monitors Neisseria gonorrhoeae antimicrobial resistance to guide treatment...

Download

Priority setting in tuberculosis programme planning: policy brief

In an era of constrained resources and tightening budgets, strategic prioritization in tuberculosis (TB) programming is more critical than ever. Countries...

Download

The WHO Global tuberculosis report 2025 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, ...

Download

Catalyzing solutions for equitable global access and sustainable financing for novel tuberculosis vaccines for adults and adolescents

This report was developed by the WHO TB Vaccine Accelerator Finance and Access working group, co-led by WHO, Gavi and the Government of South Africa. It...

Download